illumigene® Malaria Receives 1st Place Award
at the Journées Internationales de Biologie /Association des Colloques
Nationaux des Biologistes Conference in Paris
CINCINNATI, Sept 1 (Bernama-GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) was awarded 1st place for innovation in emergency treatment and point-of-care testing for itsillumigene® Malaria test at the 2016 JIB/ACNBH Conference this summer. Innovations from worldwide companies contributing to the development of the Medical Biology industry were put under the spotlight at this year’s conference held in Paris, France, and were reviewed by worldwide expert members in the medical biology field.
No comments:
Post a Comment